1Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy.Activ, inca nu recruteazaSC Oncolab SRL, Craiova, Dolj, Romania, 200385S.C. Oncocenter Oncologie Clinica S.R.L., Timisoara, Timis, Romania, 300166SC ONCOCENTER Oncologie Clinica SRL, Timisoara, Timis, Romania, 300210Spitalul Clinic C.F. 2 Bucuresti. Departament Oncologie, Sectia Medicala 2, Bucuresti, Romania, 011464             
2Pan Tumor Nivolumab Rollover StudyIn curs de recrutareLocal Institution, Bucharest, Romania, 022328, Contact: Site 0129         Local Institution, Cluj Napoca, Romania, 400015, Contact: Site 0135         Local Institution, Cluj Napoca, Romania, 400641, Contact: Site 0127         Local Institution, Oradea, Romania, 440445, Contact: Site 0133   
3A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) (CheckMate 848)In curs de recrutareLocal Institution, Bucuresti, Romania, 022328Local Institution, Cluj-Napoca, Romania, 400015Local Institution, Craiova, Romania, 200347Local Institution, Floresti, Romania, 407280Local Institution, Timisoara, Timis, Romania, 300239
4Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)Activ, inca nu recruteazaS.C Delta Health Care S.R.L, Bucuresti, Romania, 014142S.C Medisprof S.R.L., Cluj-Napoca, Romania, 400641S.C Centrul de Oncologie Sf. Nectarie S.R.L., Craiova, Romania, 200347S.C Oncocenter Oncologie Clinica S.R.L., Timişoara, Romania, 300166
5Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)In curs de recrutareS.C. Pelican Impex S.R.L Spitalul Clinic Pelican Oradea ( Site 1102), Oradea, Bihor, Romania, 410469, Contact: Study Coordinator    +40746103306      SC Radiotherapy Center Cluj SRL ( Site 1105), Comuna Floresti, Cluj, Romania, 407280, Contact: Study Coordinator    +40742206212      S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 1103), Craiova, Dolj, Romania, 200347, Contact: Study Coordinator    +40727774974      Spitalul PDR Medlife ( Site 1106), Brasov, Romania, 500152, Contact: Study Coordinator    +40722559551      S.C.Focus Lab Plus S.R.L ( Site 1101), Bucuresti, Romania, 021389, Contact: Study Coordinator    +40721298677      S.C.Gral Medical S.R.L ( Site 1104), Bucuresti, Romania, 031422, Contact: Study Coordinator    +40723954705      Medisprof ( Site 1107), Cluj Napoca, Romania, 400641, Contact: Study Coordinator    +40751274636    
6Study of Romiplostim for Chemo-induced Thrombocytopenia in Adults Subjects With Gastrointestinal or Colorectal CancerIn curs de recrutareResearch Site, Bucharest, Romania, 022328Research Site, Cluj-Napoca, Romania, 400015Research Site, Cluj-Napoca, Romania, 400124Research Site, Timisoara, Romania, 300239
7An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have SpreadIn curs de recrutareLocal Institution, Bucharest, Romania, 022328, Contact: Site 0045         Local Institution, Craiova, Romania, 200347, Contact: Site 0041  
8A Study in Participants Previously Enrolled in a Genentech− and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)In curs de recrutareProf. Dr. I. Chiricuta Institute of Oncology, Cluj Napoca, Romania, 400015Institut Oncologic Ion Chiricuta; Departament Radioterapie, Cluj-napoca, Romania, 400015ONCOMED – Medical Centre, Timisoara, Romania, 300239
9Durvalumab Long-Term Safety and Efficacy Study (WAVE)In curs de recrutareResearch Site, Craiova, Romania, 200347Research Site, Suceava, Romania, 720237
10A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella B)In curs de recrutareCentrul de Oncologie Sfantul Nectarie, Craiova, Romania, 200347
11Avelumab Program Rollover StudyIn curs de recrutareSpitalul Clinic Municipal „Dr. Gavril Curteanu” Oradea – Centrul Oncologie Medicala, Oradea, Romania, 410469, Contact:,   Principal Investigator: Simona Mihutiu  
12Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored StudiesActiv, inca nu recruteazaNovartis Investigative, Bucuresti, Romania, 011863
13AOP2014 vs. BAT in Patients With Polycythemia Vera Who Previously Participated in the PROUD-PV Study. (CONTI-PV)Activ, inca nu se recruteazaEmergency Clinical County Hospital Brasov, Brasov, RomaniaBucharest University Emergency Hospital, Bucharest, RomaniaColtea Clinical Hospital, Bucharest, Romania
14A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes (EUMDS)In curs de recrutareFundeni CLinical Institute, Clinic of Hematology, Bucharest, Romania
15NBTXR3 Crystalline Nanoparticles and Radiation Therapy in Treating Randomized Patients in Two Arms With Soft Tissue Sarcoma of the Extremity and Trunk WallActiv, inca nu se recruteazaInstitutul Oncologic Bucuresti Bucharest, Romania Spitalului Universitar de Urgenta Militar Central Bucharest, Romania Amethyst-Cluj Floresti, Romania County Hospital ‘Dr Gavril Curteanu’ Oradea, Romania County Hospital, Targu Mures Targu Mures, Romania Municipal Emergency Hospital Timisoara, Romania
(Visited 42 times, 1 visits today)